Andor W J M Glaudemans
Overview
Explore the profile of Andor W J M Glaudemans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
261
Citations
4393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Abikhzer G, Treglia G, Pelletier-Galarneau M, Buscombe J, Chiti A, Dibble E, et al.
Eur J Nucl Med Mol Imaging
. 2024 Oct;
52(2):510-538.
PMID: 39387894
Introduction: Hybrid [F]FDG PET imaging is currently the method of choice for a wide variety of infectious and inflammatory disorders and was recently adopted in several clinical guidelines. A large...
12.
van Sluis J, van Snick J, Glaudemans A, Slart R, Noordzij W, Brouwers A, et al.
J Nucl Med
. 2024 Oct;
65(10):1652-1657.
PMID: 39353647
Methods to shorten [F]FDG Patlak PET imaging procedures ranging from 65-90 to 20-30 min after injection, using a population-averaged input function (PIF) scaled to patient-specific image-derived input function (IDIF) values,...
13.
14.
Treglia G, Albano D, Rizzo A, Bellasi A, Glaudemans A, Gheysens O
Diagnostics (Basel)
. 2024 Aug;
14(15).
PMID: 39125479
Background: Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([F]FDG PET/CT) has been suggested as a useful imaging method for diagnosing cyst infections in patients with autosomal dominant polycystic kidney disease (ADPKD)....
15.
Roya M, van Snick J, Slart R, Noordzij W, Stormezand G, Willemsen A, et al.
Mol Imaging Biol
. 2024 Aug;
26(5):780-789.
PMID: 39093483
Purpose: To ensure comparable PET/CT image quality between or within centres, clinical inter-system performance comparisons following European Association of Nuclear Medicine Research Ltd. (EARL) guidelines is required. In this work...
16.
Albano D, Rizzo A, Slart R, Hess S, Noriega-Alvarez E, Gamila Wakfie-Corieh C, et al.
Pharmaceuticals (Basel)
. 2024 Jun;
17(6).
PMID: 38931383
The role of fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT) is emerging for the assessment of non-oncological diseases, such as inflammatory and infectious diseases, even if the...
17.
Jeltema H, van Dijken B, Tamasi K, Drost G, Heesters M, van der Hoorn A, et al.
Ann Nucl Med
. 2024 May;
38(8):596-606.
PMID: 38720053
Objective: C-Methionine positron emission tomography (MET-PET) is used for stereotactic radiotherapy planning in meningioma patients. The role of MET-PET during subsequent follow-up (FU) is unclear. We analyzed the uptake of...
18.
Gotuzzo I, Slart R, Gimelli A, Ashri N, Anagnostopoulos C, Bucerius J, et al.
Eur J Nucl Med Mol Imaging
. 2024 Apr;
51(7):1809-1815.
PMID: 38679624
No abstract available.
19.
Hess S, Noriega-Alvarez E, Leccisotti L, Treglia G, Albano D, Roivainen A, et al.
Eur J Nucl Med Mol Imaging
. 2024 Apr;
51(9):2597-2613.
PMID: 38676736
Purpose: Patients with fever and inflammation of unknown origin (FUO/IUO) are clinically challenging due to variable clinical presentations with nonspecific symptoms and many differential diagnoses. Positron emission tomography/computed tomography (PET/CT)...
20.
Aghayev A, Weber B, de Carvalho T, Glaudemans A, Nienhuis P, van der Geest K, et al.
J Nucl Cardiol
. 2024 Apr;
37:101864.
PMID: 38663459
Different types of vasculitis can be distinguished according to the blood vessel's size that is preferentially affected: large-vessel, medium-vessel, and small-vessel vasculitides. Giant cell arteritis (GCA) and Takayasu's arteritis (TAK)...